Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsy
{{output}}
Enfortumab vedotin (EV), an antibody-drug conjugate targeting Nectin-4, has demonstrated efficacy against advanced urothelial carcinoma. While initially considered rare, EV-induced interstitial lung disease (ILD) is increasingly recognized, yet its pathologica... ...
